一个基因分析指南,以支持淋巴瘤的诊断和临床管理
Margarita Sánchez-Beato1,2, Miriam Méndez3,4,5, María Guirado4,6
1Servicio de Oncología Médica, Grupo de Investigación en Linfomas, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain. msbeato@idiphim.org.
概括
新的淋巴瘤分类将遗传学整合起来,以改善诊断和风险分层. 下一代测序对于在成熟的淋巴瘤中识别遗传标记至关重要,指导治疗决策.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 最近的淋巴瘤分类 (ICC和世卫组织第5版) 在诊断方面强调遗传学.
- 淋巴瘤遗传学是复杂的,具有很少的反复突变和广泛的低频变化的景观.
- 遗传标记在淋巴瘤诊断和预后方面越来越重要.
研究的目的:
- 为淋巴瘤分析提供下一代测序 (NGS) 指南.
- 审查具有临床意义的常见成熟淋巴瘤实体中的遗传变化.
- 为B细胞和NK/T细胞淋巴瘤提出针对性的测序小组.
主要方法:
- 关于淋巴瘤遗传学和分类的当前文献的综述.
- 对诊断,预后和预测遗传标记的讨论.
- 针对突变和副本数量改变检测的目标NGS面板的建议.
主要成果:
- 遗传学是现代淋巴瘤分类的组成部分,使得细化的亚型和风险评估.
- NGS对于检测淋巴瘤中的关键遗传变异至关重要.
- 特定的遗传标记在淋巴瘤亚型中提供诊断,预后和预测价值.
结论:
- 将基因分析整合到淋巴瘤诊断中可以改善患者分层和治疗反应预测.
- 建议针对性NGS小组进行B细胞和NK/T细胞淋巴瘤的综合遗传分析.
- 该综述是NGS在淋巴瘤诊断中的临床应用的实用指南.
更多相关视频
13:21Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
Published on: June 16, 2017
10.1K
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
21.2K
相关概念视频
Karyotyping
Describing the number and physical features of chromosomes can reveal abnormalities that underlie genetic diseases. This description is facilitated by special staining techniques that produce a particular banding pattern on each chromosome. State-of-the-art techniques make this approach even more powerful, enabling the detection of individual genes that cause disease.A Simple Chromosome Staining Technique Provides Valuable Scientific InsightSome genetic diseases can be detected by looking at...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
